Prolocor
Debra brings more than 25 years’ experience in drug development from J&J and TAP Pharmaceuticals. She played a leading role in the Xarelto® development program, and she brings extensive experience in NDA and sNDA submissions with the FDA and applications for marketing authorization globally.
Debra holds a MS in Clinical Chemistry from Old Dominion University.
This person is not in any teams
This person is not in any offices
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.